Many people using GLP-1s for weight loss stop treatment too soon, research shows, and results are not one-size-fits-all
The analysis from Dandelion Health, a health care analytics firm, is based on the electronic health records of nearly 17,000 ...
STAT29d
Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
and served as White House Domestic Policy Council director to President Trump from 2019-20. President Biden took a groundbreaking step in proposing to cover GLP-1 obesity medications under ...
Morningstar25d
2 Companies Poised to Capitalize on the Rise of GLP-1 Drugs
In the US alone, the number of patients starting GLP-1 treatments for nondiabetic purposes has increased by 700% since 2019, highlighting the popularity of these drugs beyond their original aim of ...